Effects of low‐dose remifentanil infusion on analgesic or antiemetic requirement during brain function mapping: A retrospective cohort study

Background Pain and discomfort during the awake phase in awake craniotomy should be relieved to facilitate brain mapping. Although some anaesthesiologists use low‐dose (0.01‐0.05 µg/kg/min) remifentanil infusion to provide analgesia during this phase, its efficacy and side effects have never been ev...

Ausführliche Beschreibung